Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
a2ntx (1 trial)
alfacalcidol (2 trials)
eldecalcitol (2 trials)
methylcobalamin (1 trial)
rimabotulinumtoxinB (Myobloc) (1 trial)
metal allergen (1 trial)
Amyotrophic Lateral Sclerosis (Phase 3)
Dermatitis (Phase 2)
Eczema (Phase 2)
Motor Neuron Disease (Phase 3)
Muscle Spasticity (Phase 3)
Osteoporosis (Phase 3)
Sclerosis (Phase 3)
Stroke (Phase 3)
Trials (5 total)
Trial APIs (6 total)